91 related articles for article (PubMed ID: 17456929)
1. Use of fumaric acid esters in psoriasis.
Roll A; Reich K; Boer A
Indian J Dermatol Venereol Leprol; 2007; 73(2):133-7. PubMed ID: 17456929
[TBL] [Abstract][Full Text] [Related]
2. Oral fumaric acid esters for psoriasis: abridged Cochrane systematic review including GRADE assessments.
Atwan A; Ingram JR; Abbott R; Kelson MJ; Pickles T; Bauer A; Piguet V
Br J Dermatol; 2016 Nov; 175(5):873-881. PubMed ID: 27087044
[TBL] [Abstract][Full Text] [Related]
3. No evidence for interactions of dimethylfumarate (DMF) and its main metabolite monomethylfumarate (MMF) with human cytochrome P450 (CYP) enzymes and the P-glycoprotein (P-gp) drug transporter.
Aubets J; Jansat JM; Salva M; Birks VM; Cole RJ; Lewis J; Pitcher A; Hall M
Pharmacol Res Perspect; 2019 Dec; 7(6):e00540. PubMed ID: 31832203
[TBL] [Abstract][Full Text] [Related]
4. Fumaric acid therapy in psoriasis: results and side effects of 2 years of treatment.
Kolbach DN; Nieboer C
J Am Acad Dermatol; 1992 Nov; 27(5 Pt 1):769-71. PubMed ID: 1430403
[No Abstract] [Full Text] [Related]
5. Treatment of disseminated granuloma annulare with fumaric acid esters.
Kreuter A; Gambichler T; Altmeyer P; Brockmeyer NH
BMC Dermatol; 2002 Mar; 2():5. PubMed ID: 11914154
[TBL] [Abstract][Full Text] [Related]
6. Discontinuation of Fumaric Acid Esters is Affected by Depressive Symptomatology: A Retrospective Analysis.
Krefting F; Hölsken S; Schedlowski M; Sondermann W
Acta Derm Venereol; 2024 Mar; 104():adv12326. PubMed ID: 38483082
[TBL] [Abstract][Full Text] [Related]
7. Real-life experience with dimethylfumarate in palmoplantar psoriasis: A multicentre retrospective Italian study.
Giacomo C; Emanuele T; Martina B; Eugenio C; Federico D; Viviana L; Maria PL; Ruslana GS; Thais FM; Marco M; Elena C; Annamaria O; Aurora P; Francesca P
Australas J Dermatol; 2024 Jun; 65(4):e92-e96. PubMed ID: 38268135
[TBL] [Abstract][Full Text] [Related]
8. Role of dimethyl fumarate in the treatment of glioblastoma multiforme: A review article.
Ahmadi-Beni R; Najafi A; Savar SM; Mohebbi N; Khoshnevisan A
Iran J Neurol; 2019 Jul; 18(3):127-133. PubMed ID: 31749934
[TBL] [Abstract][Full Text] [Related]
9. Fumaric Acid and its esters: an emerging treatment for multiple sclerosis.
Moharregh-Khiabani D; Linker RA; Gold R; Stangel M
Curr Neuropharmacol; 2009 Mar; 7(1):60-4. PubMed ID: 19721818
[TBL] [Abstract][Full Text] [Related]
10. Selective activation of cellular stress response pathways by fumaric acid esters.
Erler K; Krafczyk N; Steinbrenner H; Klotz LO
FEBS Open Bio; 2024 May; ():. PubMed ID: 38794848
[TBL] [Abstract][Full Text] [Related]
11. Prior exposure to fumaric acid esters does not impact on subsequent treatment response to guselkumab.
Kearney N; Kirby B
Br J Dermatol; 2024 Jan; ():. PubMed ID: 38282352
[No Abstract] [Full Text] [Related]
12. Fumaderm® in daily practice for psoriasis: dosing, efficacy and quality of life.
Walker F; Adamczyk A; Kellerer C; Belge K; Brück J; Berner T; Merten K; Núnez Gómez N; Neureither M; Röcken M; Ghoreschi K;
Br J Dermatol; 2014 Nov; 171(5):1197-205. PubMed ID: 24813676
[TBL] [Abstract][Full Text] [Related]
13. Fumaric acid esters for psoriasis: a systematic review.
Smith D
Ir J Med Sci; 2017 Feb; 186(1):161-177. PubMed ID: 27271164
[TBL] [Abstract][Full Text] [Related]
14. Dimethylfumarate for psoriasis: Pronounced effects on lesional T-cell subsets, epidermal proliferation and differentiation, but not on natural killer T cells in immunohistochemical study.
Bovenschen HJ; Langewouters AM; van de Kerkhof PC
Am J Clin Dermatol; 2010; 11(5):343-50. PubMed ID: 20553063
[TBL] [Abstract][Full Text] [Related]
15. Oral fumaric acid esters for psoriasis.
Atwan A; Ingram JR; Abbott R; Kelson MJ; Pickles T; Bauer A; Piguet V
Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD010497. PubMed ID: 26258748
[TBL] [Abstract][Full Text] [Related]
16. Fumaric acid esters.
Rostami Yazdi M; Mrowietz U
Clin Dermatol; 2008; 26(5):522-6. PubMed ID: 18755371
[TBL] [Abstract][Full Text] [Related]
17. Treatment of psoriasis with fumaric acid esters (Fumaderm).
Mrowietz U; Altmeyer P; Bieber T; Röcken M; Schopf RE; Sterry W
J Dtsch Dermatol Ges; 2007 Aug; 5(8):716-7. PubMed ID: 17659047
[No Abstract] [Full Text] [Related]
18. Treatment of severe, recalcitrant, chronic plaque psoriasis with fumaric acid esters: a prospective study.
Wain EM; Darling MI; Pleass RD; Barker JN; Smith CH
Br J Dermatol; 2010 Feb; 162(2):427-34. PubMed ID: 19519838
[TBL] [Abstract][Full Text] [Related]
19. Drug survival of fumaric acid esters for psoriasis: a retrospective study.
Ismail N; Collins P; Rogers S; Kirby B; Lally A
Br J Dermatol; 2014 Aug; 171(2):397-402. PubMed ID: 24471408
[TBL] [Abstract][Full Text] [Related]
20. Fumaric acid therapy in psoriasis: a double-blind comparison between fumaric acid compound therapy and monotherapy with dimethylfumaric acid ester.
Nieboer C; de Hoop D; Langendijk PN; van Loenen AC; Gubbels J
Dermatologica; 1990; 181(1):33-7. PubMed ID: 2394301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
